Genome-Wide Analysis Studies and Chronic Kidney Disease

Abstract

In recent years, the very high worldwide prevalence of chronic kidney disease (CKD) has led some authors to talk of an “epidemic.” The progression of CKD varies considerably among individuals despite similar aetiologies, optimal blood pressure, and glycaemic control. Over the last decade, through genome-wide association studies (GWAS), more than 50 genetic loci have been identified in association with CKD. Understanding the genetic basis of CKD could provide a better knowledge of the biology of the involved pathways, thus potentially leading to novel tools for the diagnosis, prevention, and therapy of CKD. In this review, we will analyse the role of GWAS in the study of CKD.